← Scroll for more →
ImmunityBio, Inc. (IBRX)
Biological Products, (No Diagnostic Substances)
Latest Price
$8.29
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
20.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 34.08M | $298.0M | 3.24% | +7.74M | 2026-06-30 |
| State Street Corp | 21.40M | $187.0M | 2.03% | +3.69M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 17.86M | $156.0M | 1.70% | +1.54M | 2026-06-30 |
| Vanguard Capital Management LLC | 15.69M | $137.0M | 1.49% | +563.9K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 11.55M | $101.0M | 1.10% | -1.02M | 2026-06-30 |
| Two Sigma Investments, LP | 11.10M | $97.0M | 1.05% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 9.85M | $86.0M | 0.94% | +1.82M | 2026-06-30 |
| Citadel Advisors LLC | 5.67M | $49.0M | 0.54% | +538.8K | 2026-06-30 |
| Millennium Management LLC | 5.58M | $48.0M | 0.53% | +4.14M | 2026-06-30 |
| LMR Partners LLP | 4.25M | $37.0M | 0.40% | -93.8K | 2026-06-30 |